Roberto Martegani
Research Subjects
Research Interests
Roberto Martegani has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Filippo Speranza
Department of Infectious Diseases, General Hospital and Macchi Foundation, Viale Borri 57, 21100 Varese, Italy
8 shared publicationsClaudia Zeroli
7 shared publicationsDonato Torre
Department of Infectious Diseases, Regional Hospital, Varese, University of Turin, Turin, Italy
6 shared publicationsD. Torre
Div. of Infectious Diseases, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
4 shared publicationsAgostino Pugliese
Department of Infectious Diseases, Regional Hospital, Varese, University of Turin, Turin, Italy
3 shared publicationsD Torre
3 shared publications
Latest Publications
- 8 March 2005
- Published by Wiley in HIV Medicine
- Vol. 6 (2) , 66-78
Impact of highly active antiretroviral therapy on organ‐specific manifestations of HIV‐1 infection
In the last 10 years, interesting results have been reported concerning the impact of highly active antiretroviral therapy (HAART) on the changing pattern of organ‐specific manifestations of HIV‐1 infection. There has been a clear step‐wise reduction in the incidence of several opportunistic infections (OIs), particularly Pneumocystis carinii pneumonia, whereas a nonsignificant reduction in incidence has been observed for other organ‐specific diseases, including invasive cervical cancer and Hodgkin disease. In addition, several organ‐specific manifestations, including HIV‐associated nephropathy, wasting syndrome and cardiomiopathy, are a direct consequence of damage by HIV‐1, and so HAART may have a therapeutic effect in improving or preventing these manifestations. Finally, the introduction of HAART has seen the emergence of several complications, termed immune reconstitution inflammatory syndrome, which includes OIs such as cytomegalovirus vitritis, Mycobacterium avium complex lymphadenitis, paradoxical responses to treatment for tuberculosis, and exacerbation of cryptococcosis. Because not all HIV‐1 organ‐specific manifestations are decreasing in the HAART era, this review will analyse the influence of HAART on several organ‐specific manifestations, and in particular OIs related to several organs, cerebral disorders and HIV‐1‐related neoplasia.
- 8 March 2005
- Published by Wiley in HIV Medicine
- Vol. 6 (2) , 66-78
Impact of highly active antiretroviral therapy on organ‐specific manifestations of HIV‐1 infection
In the last 10 years, interesting results have been reported concerning the impact of highly active antiretroviral therapy (HAART) on the changing pattern of organ‐specific manifestations of HIV‐1 infection. There has been a clear step‐wise reduction in the incidence of several opportunistic infections (OIs), particularly Pneumocystis carinii pneumonia, whereas a nonsignificant reduction in incidence has been observed for other organ‐specific diseases, including invasive cervical cancer and Hodgkin disease. In addition, several organ‐specific manifestations, including HIV‐associated nephropathy, wasting syndrome and cardiomiopathy, are a direct consequence of damage by HIV‐1, and so HAART may have a therapeutic effect in improving or preventing these manifestations. Finally, the introduction of HAART has seen the emergence of several complications, termed immune reconstitution inflammatory syndrome, which includes OIs such as cytomegalovirus vitritis, Mycobacterium avium complex lymphadenitis, paradoxical responses to treatment for tuberculosis, and exacerbation of cryptococcosis. Because not all HIV‐1 organ‐specific manifestations are decreasing in the HAART era, this review will analyse the influence of HAART on several organ‐specific manifestations, and in particular OIs related to several organs, cerebral disorders and HIV‐1‐related neoplasia.
- 1 December 2002
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 2 (12) , 719-720
Role of proinflammatory and anti-inflammatory cytokines in the immune response to Plasmodium falciparum malaria
- 1 December 2002
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 2 (12) , 719-720
Role of proinflammatory and anti-inflammatory cytokines in the immune response to Plasmodium falciparum malaria
- Open Access
- 1 April 2002
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 185 (7) , 998-9
Role of interleukin-18 in human immunodeficiency virus type 1 infection.
To the Editor—In a recent in vitro study, Choi et al. [1] demonstrated that interleukin (IL)-18 inhibits human immunodeficiency virus (HIV) type 1 production in peripheral blood mononuclear cells (PBMC), and they concluded that IL-18 blocked HIV-1 production in PBMC through intermediate interferon-γ, suggesting that IL-18, as an inducer of the Th1-type response, may be a therapeutic candidate for the inhibition of HIV-1 replication in infected patients. In a previous study, Shapiro et al. [2] showed that, in vitro, IL-18 stimulated HIV-1 production in a chronically infected promonocytic cell line, U1. Subsequently, Klein et al. [3] found that IL-18 also stimulates HIV-1 production in an acutely infected Hut78 T cell line.
- 1 April 2002
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 185 (7) , 998-9
Open AccessRole of interleukin-18 in human immunodeficiency virus type 1 infection.
To the Editor—In a recent in vitro study, Choi et al. [1] demonstrated that interleukin (IL)-18 inhibits human immunodeficiency virus (HIV) type 1 production in peripheral blood mononuclear cells (PBMC), and they concluded that IL-18 blocked HIV-1 production in PBMC through intermediate interferon-γ, suggesting that IL-18, as an inducer of the Th1-type response, may be a therapeutic candidate for the inhibition of HIV-1 replication in infected patients. In a previous study, Shapiro et al. [2] showed that, in vitro, IL-18 stimulated HIV-1 production in a chronically infected promonocytic cell line, U1. Subsequently, Klein et al. [3] found that IL-18 also stimulates HIV-1 production in an acutely infected Hut78 T cell line.
- 1 December 2000
- Published by Elsevier in Microbes and Infection
- Vol. 2 (15) , 1831-1833
Levels of the bcl-2 protein, fibronectin and α5β1 fibronectin receptor in HIV-1-infected patients with Kaposi’s sarcoma
- 1 December 2000
- Published by Elsevier in Microbes and Infection
- Vol. 2 (15) , 1831-1833
Levels of the bcl-2 protein, fibronectin and α5β1 fibronectin receptor in HIV-1-infected patients with Kaposi’s sarcoma
- 1 September 2000
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (14) , 2211-2
Circulating levels of IL-18 in adult and paediatric patients with HIV-1 infection
- 1 September 2000
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (14) , 2211-2
Circulating levels of IL-18 in adult and paediatric patients with HIV-1 infection
- 1 October 1999
- Vol. 22 (4) , 281-91
Diagnostic value of viral culture, polymerase chain reaction and western blot for HIV-1 infection in 218 infants born to HIV-infected mothers and examined at different ages.
In a prospective longitudinal 10-year (1988 to 1998) study, 308 sequential blood samples from 218 infants born to HIV-1 seropositive women were examined by blood culture, polymerase chain reaction (PCR) and Western Blot (WB) for HIV-1 infection within the first month of life (no. 47 specimens), at 2-6 (no. 125), 7-18 (no. 80), and > 18 (no. 56) months after birth. Clinical status at follow-up after the initial diagnosis of HIV infection was also evaluated. Vertically transmitted HIV infection was diagnosed in 45 children (24 children were diagnosed before 18 months of age), whereas 173 were found to be uninfected (transmission rate 20.6%). Sensitivities of viral culture, PCR and WB were 95.2%, 97.8%, 94.4%, and specificities were 99.5%, 97.6% and 20.7%, respectively. Thus, cumulative positive predictive values (PPV) of blood culture, PCR and WB were 97.5%, 88.2% and 23.4%, while negative predictive values (NPV) were 99.0%, 99.6% and 100.0%, respectively. In view of defining the optimal time of sampling for a correct diagnosis of HIV infection, a PPV of 100.0% was achieved earlier by viral culture (2-6 months of age) than by PCR (7-18 months of age). Meanwhile, a NPV of 100% was obtained earlier by PCR (within the first month of age) than by viral culture (2-6 months). These results indicate that a combination test strategy requiring two blood samples analyzed by viral culture and PCR may confirm or exclude HIV perinatal infection within the first 2 months of life rather than being delayed to later times. Clinical follow-up was performed in 35 children, of whom 7 developed a rapidly progressive disease, 23 showed a slow progression, while 5 children are still younger than 5 years and do not present severe clinical symptoms.
- 1 October 1999
- Vol. 22 (4) , 281-91
Diagnostic value of viral culture, polymerase chain reaction and western blot for HIV-1 infection in 218 infants born to HIV-infected mothers and examined at different ages.
In a prospective longitudinal 10-year (1988 to 1998) study, 308 sequential blood samples from 218 infants born to HIV-1 seropositive women were examined by blood culture, polymerase chain reaction (PCR) and Western Blot (WB) for HIV-1 infection within the first month of life (no. 47 specimens), at 2-6 (no. 125), 7-18 (no. 80), and > 18 (no. 56) months after birth. Clinical status at follow-up after the initial diagnosis of HIV infection was also evaluated. Vertically transmitted HIV infection was diagnosed in 45 children (24 children were diagnosed before 18 months of age), whereas 173 were found to be uninfected (transmission rate 20.6%). Sensitivities of viral culture, PCR and WB were 95.2%, 97.8%, 94.4%, and specificities were 99.5%, 97.6% and 20.7%, respectively. Thus, cumulative positive predictive values (PPV) of blood culture, PCR and WB were 97.5%, 88.2% and 23.4%, while negative predictive values (NPV) were 99.0%, 99.6% and 100.0%, respectively. In view of defining the optimal time of sampling for a correct diagnosis of HIV infection, a PPV of 100.0% was achieved earlier by viral culture (2-6 months of age) than by PCR (7-18 months of age). Meanwhile, a NPV of 100% was obtained earlier by PCR (within the first month of age) than by viral culture (2-6 months). These results indicate that a combination test strategy requiring two blood samples analyzed by viral culture and PCR may confirm or exclude HIV perinatal infection within the first 2 months of life rather than being delayed to later times. Clinical follow-up was performed in 35 children, of whom 7 developed a rapidly progressive disease, 23 showed a slow progression, while 5 children are still younger than 5 years and do not present severe clinical symptoms.
- 1 November 1998
- Published by Springer Nature in Infection
- Vol. 26 (6) , 402-404
Meningoencephalitis caused by human herpesvirus-6 in an immunocompetent adult patient: Case report and review of the literature
Human herpesvirus-6 (HHV-6) is the etiologic agent of roseola infantum, and has been implicated as a possible cause of encephalitis in pediatric and adult patients. A case of meningoencephalitis in an otherwise healthy, immunocompetent 59-year-old woman is described. The diagnosis of HHV-6 meningoencephalitis was confirmed by detecting viral DNA in cerebrospinal fluid collected in the acute stage of the disease by polymerase chain reaction. The patient was treated with acyclovir and recovered without any sequelae. The current knowledge of the pathophysiology, clinical course and outcome of HHV-6 meningoencephalitis in immunocompetent adult patients is also reviewed.
- 1 November 1998
- Published by Springer Nature in Infection
- Vol. 26 (6) , 402-404
Meningoencephalitis caused by human herpesvirus-6 in an immunocompetent adult patient: Case report and review of the literature
Human herpesvirus-6 (HHV-6) is the etiologic agent of roseola infantum, and has been implicated as a possible cause of encephalitis in pediatric and adult patients. A case of meningoencephalitis in an otherwise healthy, immunocompetent 59-year-old woman is described. The diagnosis of HHV-6 meningoencephalitis was confirmed by detecting viral DNA in cerebrospinal fluid collected in the acute stage of the disease by polymerase chain reaction. The patient was treated with acyclovir and recovered without any sequelae. The current knowledge of the pathophysiology, clinical course and outcome of HHV-6 meningoencephalitis in immunocompetent adult patients is also reviewed.
- 1 July 1998
- Published by Elsevier in Journal of Infection
- Vol. 37 (1) , 36-38
A retrospective study on the efficacy and safety of amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients
- 1 July 1998
- Published by Elsevier in Journal of Infection
- Vol. 37 (1) , 36-38
A retrospective study on the efficacy and safety of amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients
- 1 January 1998
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 30 (6) , 565-568
Serum Levels of Fas/Apo-1 and Bcl-2 in Children with HIV-1 Infection
Apoptosis of CD4-positive T cells is considered to be involved in depletion of CD4-positive T cells in adult patients with HIV-1 infection. In this report we evaluated serum levels of soluble Fas/Apo-1 and circulating bcl-2 protein (an antiapoptotic molecule) in HIV-1-infected children, and 30 HIV-1 seronegative children. Significantly higher levels of Fas/Apo-1 were observed in 13 HIV-1-infected children than in non-infected control children (p0.001), whereas serum levels of bcl-2 were significantly decreased (p=0.002). Seronegative children born to HIV-infected mothers displayed significantly decreased (p0.05) serum levels of bcl-2. By contrast, children born to HIV-seronegative mothers and suffering from acute lower respiratory infection had normal levels of bcl-2 and Fas/Apo-1. These data suggest that upregulation of Fas/Apo-1 along with downregulation of bcl-2 protein may contribute to apoptosis in children with HIV-1 infection.
- 1 January 1998
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 30 (6) , 565-568
Serum Levels of Fas/Apo-1 and Bcl-2 in Children with HIV-1 Infection
Apoptosis of CD4-positive T cells is considered to be involved in depletion of CD4-positive T cells in adult patients with HIV-1 infection. In this report we evaluated serum levels of soluble Fas/Apo-1 and circulating bcl-2 protein (an antiapoptotic molecule) in HIV-1-infected children, and 30 HIV-1 seronegative children. Significantly higher levels of Fas/Apo-1 were observed in 13 HIV-1-infected children than in non-infected control children (p0.001), whereas serum levels of bcl-2 were significantly decreased (p=0.002). Seronegative children born to HIV-infected mothers displayed significantly decreased (p0.05) serum levels of bcl-2. By contrast, children born to HIV-seronegative mothers and suffering from acute lower respiratory infection had normal levels of bcl-2 and Fas/Apo-1. These data suggest that upregulation of Fas/Apo-1 along with downregulation of bcl-2 protein may contribute to apoptosis in children with HIV-1 infection.
- Open Access
- 1 May 1996
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 22 (5) , 883-884
Levels of Interleukin-10 and Tumor Necrosis Factor in Patients with Bacterial Meningitis
- 1 May 1996
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 22 (5) , 883-884
Open AccessLevels of Interleukin-10 and Tumor Necrosis Factor in Patients with Bacterial Meningitis